Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TapImmune Inc (OTCQB:TPIV)

0.385
Delayed Data
As of 11:06am ET
 -0.005 / -1.28%
Today’s Change
0.12
Today|||52-Week Range
1.71
+37.50%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Revenue and IncomeNet Revenues0.000.000.000.00--
 
Operating ExpensesGross Income0.000.000.000.00--
General Expenses1.4M394.2K1.0M1.1M
 
 
 
 
 
Research And Development32.5K111.5K609.4K201.2K
 
 
 
 
 
Total Operating Expenses1.4M394.2K1.0M1.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.4M-394.2K-1.0M-1.1M
 
 
 
 
 
Extraordinary Credit----46.4K0.00
 
 
Extraordinary Charge-168.7K-289.3K0.00-17.3M
 
 
 
 
Interest Expense On Debt15.4K0.000.000.00
 
 
Other Expenses0.00-53.0K0.00775.00
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.6M-736.5K-981.7K-18.4M
 
 
 
 
 
Net Income-1.6M-736.5K-981.7K-18.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS17.3M20.3M27.6M33.5M
 
 
 
 
 
Shares To Calculate EPS Diluted17.3M20.3M27.6M33.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.09-$0.04-$0.04-$0.55
 
 
 
 
 
EPS Diluted-$0.09-$0.04-$0.04-$0.55